影像引导活检独立组织学验证脑肿瘤MR细胞密度预测图
CPM在初治患者中能准确预测组织学细胞密度(b=1.4,R2=0.2,p=0.009,rho=0.41,p=0.016,RMSE=1503 cell/mm2),但在复发亚组中无此关联;ADC也仅在初治患者中与细胞密度显著相关,且CPM未明显优于ADC。
要点
- CPM在初治胶质瘤中可无创评估肿瘤细胞密度,复发患者不适用。
- CPM对细胞密度的预测效能与ADC单独使用相比无明显优势。
- 影像引导活检组织学细胞计数可作为细胞密度预测图的外部验证方法。
核心结论
- MRI衍生的机器学习细胞密度预测图(CPM)可在初治胶质瘤患者中无创评估肿瘤细胞密度,但在本队列中未明显优于ADC。
研究设计与样本
- 所有患者术前按标准化脑肿瘤成像方案行MRI,评估CPM值与组织学细胞密度、ADC与组织学细胞密度的相关性。
主要发现
- CPM值在初治患者中准确预测组织学细胞密度(b=1.4,R2=0.2,p=0.009,rho=0.41,p=0.016,RMSE=1503 cell/mm2),但在复发亚组中无此关联。
- ADC值仅在初治患者中与组织学细胞密度显著相关(b=1.3,R2=0.22,p=0.007;rho=-0.37,p=0.03),与CPM相关性无统计学差异。
- 考虑非独立观测的统计检验证实上述结果。
临床怎么用
- 对于初治胶质瘤患者,可考虑使用CPM无创评估肿瘤细胞密度以辅助手术规划。
- 在复发胶质瘤中,CPM的细胞密度预测价值有限,需谨慎解读。
- CPM与ADC在预测细胞密度方面效能相当,临床选择需结合实际情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In brain gliomas, non-invasive biomarkers reflecting tumor cellularity would be useful to guide supramarginal resections and to plan stereotactic biopsies. We aim to validate a previously-trained machine learning algorithm that generates cellularity prediction maps (CPM) from multiparametric MRI data to an independent, retrospective external cohort of gliomas undergoing image-guided biopsies, and to compare the performance of CPM and diffusion MRI apparent diffusion coefficient (ADC) in predicting cellularity. METHODS: A cohort of patients with treatment-naïve or recurrent gliomas were prospectively studied. All patients underwent pre-surgical MRI according to the standardized brain tumor imaging protocol. The surgical sampling site was planned based on image-guided biopsy targets and tissue was stained with hematoxylin-eosin for cell density count. The correlation between MRI-derived CPM values and histological cellularity, and between ADC and histological cellularity, was evaluated both assuming independent observations and accounting for non-independent observations. RESULTS: Sixty-six samples from twenty-seven patients were collected. Thirteen patients had treatment-naïve tumors and fourteen had recurrent lesions. CPM value accurately predicted histological cellularity in treatment-naïve patients (b = 1.4, R2 = 0.2, p = 0.009, rho = 0.41, p = 0.016, RMSE = 1503 cell/mm2), but not in the recurrent sub-cohort. Similarly, ADC values showed a significant association with histological cellularity only in treatment-naive patients (b = 1.3, R2 = 0.22, p = 0.007; rho = -0.37, p = 0.03), not statistically different from the CPM correlation. These findings were confirmed with statistical tests accounting for non-independent observations. CONCLUSION: MRI-derived machine learning generated cellularity prediction maps (CPM) enabled a non-invasive evaluation of tumor cellularity in treatment-naïve glioma patients, although CPM did not clearly outperform ADC alone in this cohort.
引用
- Nocera G, Sanvito F, Yao J, et al. Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumors. J Neurooncol. 2025. PMID: 40542949. doi:10.1007/s11060-025-05105-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。